Covid-19: Swedish company Cyxone wants to test its drug in Ukraine

Source : 112 Ukraine

Cyxone has applied to test its Rabeximod drug in Ukraine
22:12, 18 January 2021


Cyxone, a Swedish biotechnology company, has applied to test its Rabeximod drug in Ukrain, a press release on Cyxone website reads.

The company has also submitted test applications in Slovakia and Hungary.

Related: Covid-19 vaccination begins in 46 countries, - WHO

The trial will evaluate the efficacy and safety of oral treatment with Rabeximod to prevent disease progression in hospitalized Covid-19 patients. Rabeximod is being evaluated in patients suffering from moderate Covid-19 in need of oxygen treatment but not ventilator support.

The study will include 300 patients at clinical centers in Poland, Slovakia, and up to three additional countries in Europe.

Related: Norway moves to calm vaccine anxiety after elderly deaths

Preliminary results Cyxone plans to announce in the third quarter of 2021.

Meanwhile, the first stage of vaccination against coronavirus may begin in Ukraine in mid-February 2021.

“We (the Servant of the People faction, - 112 International) invited Healthcare Minister Stepanov to an online meeting to discuss the issue of vaccination in general and, in particular, regarding its stages. The Minister confirmed that the first stage of vaccination could begin approximately in mid-February this year. And at the first stage, according to the already adopted plan, they will vaccinate doctors who directly work with Covid patients, the military personnel who are in the environmental protection zone, as well as social workers and patients of geriatric boarding houses," deputy head of the Servant of the People faction Yevhenia Kravchuk said.

Related: EU to set target for vaccinating 70% of its population by summer

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more
latest news
editor's choice